http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020187838-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c915886666f6f9cd791df489c0dbae9f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-201 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-1455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
filingDate | 2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fffd464c1b5abc19466dea88b36a6d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb5c77836cb1d60754451d0ef89b27ec |
publicationDate | 2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2020187838-A1 |
titleOfInvention | Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therapy |
abstract | Disclosed herein is a method for determining a dosing prescription for a medicament in a patient undergoing CRRT. The method generally includes administering to the bloodstream of the patient a fluorescent agent; administering to the patient at least one dose of the medicament; performing CRRT on the patient after administering the fluorescent agent to the patient; exposing the fluorescent agent to visible or infrared light; monitoring transcutaneously a change in the spectral energy from the fluorescent agent over a period of time; correlating a change in intensity of the spectral energy from the fluorescent agent to a clearance rate of the fluorescent agent from the bloodstream in the patient; calculating a clearance rate of the medicament in the patient; determining an amount of the medicament in the bloodstream of the patient as a function of time; and adjusting a dosing prescription of the medicament to the patient. |
priorityDate | 2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 304.